COMPARISON OF TRADITIONAL AND NOVEL HEMOSTATIC PARAMETERS IN CHILDREN WITH ITP
Keywords:
Idiopathic thrombocytopenic purpura, pediatric hematology, traditional hemostatic parameters, novel hemostatic markers, platelet function, thromboelastography, bleeding risk, thrombocytopeniaAbstract
This study evaluates the comparative utility of traditional versus novel hemostatic parameters in children diagnosed with idiopathic thrombocytopenic purpura (ITP). While platelet counts and standard coagulation tests remain the primary diagnostic tools, emerging markers such as platelet activation assays, thromboelastography, and endothelial function indicators provide additional insights into bleeding risk and disease severity. The study highlights differences in predictive value between conventional and advanced markers, emphasizing the importance of integrating novel hemostatic assessments for comprehensive evaluation and personalized management of pediatric ITP.
References
1. Bussel, J. B., & George, J. N. (2006). Idiopathic thrombocytopenic purpura: Diagnosis and management. New England Journal of Medicine, 354(3), 290– 301.
2. Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L., & Crowther, M. A. (2011). The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood, 117(16), 4190–4207.
3. Provan, D., Stasi, R., Newland, A. C., Blanchette, V., Bolton-Maggs, P., Bussel, J. B., … & Rodeghiero, F. (2010). International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115(2), 168–186.
4. Blanchette, V., & Bussel, J. B. (2004). Pediatric thrombocytopenia: Pathophysiology and clinical management. Hematology/Oncology Clinics of North America, 18(6), 1267–1285.
5. Cines, D. B., & Blanchette, V. S. (2002). Immune thrombocytopenic purpura. New England Journal of Medicine, 346(13), 995–1008.
6. Michelson, A. D. (2012). Platelets. 3rd Edition. Academic Press.
7. Alarcón, M., & Gutiérrez, J. (2015). Platelet activation markers in pediatric thrombocytopenia. Hematology Reports, 7(2), 5987.
8. McMillan, R. (2007). The pathogenesis of chronic immune thrombocytopenic purpura. Seminars in Hematology, 44(4), S3–S11.
9. Cooper, N., & Bussel, J. (2006). The pathogenesis of immune thrombocytopenic purpura. British Journal of Haematology, 133(4), 364–374. 10.Schiffer, C. A., & Bussel, J. B. (2004). Thrombocytopenia in children and adults: Diagnostic approaches. Hematology, 2004(1), 22–30.
